EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).
Company Details
- Employees
- 2
- Address
- Cambridge Research Park Beach Drive, Building 1000,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.epilepsygtx.com
- Keywords
- Cambridge.
- HQ
- Cambridge
Epilepsygtx Questions
Epilepsygtx's website is http://www.epilepsygtx.com
Epilepsygtx's LinkedIn profile is https://uk.linkedin.com/company/epilepsygtx
Epilepsygtx has
2 employees.
View email and phone details for 2
employees at Epilepsygtx.
Epilepsygtx's industry is
Biotechnology Research
Epilepsygtx's top competitors are
Karla Therapeutics,
Brainpatch,
Blackfinbio,
Adicet Bio, Inc,
Spur Therapeutics,
Eg 427,
Zelluna,
Glialign,
Innovation Forum,
Albionvc.
Epilepsygtx's categories are Biotechnology Research
